CSIMarket
 


Dermtech Inc   (DMTK)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Dermtech Inc 's Tangible Leverage Ratio

DMTK's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth


In Spite of the repayements of liabilities of -6.04%, in III Quarter 2023 ,Tangible Leverage Ratio deteriorated to 0.89, below the Dermtech Inc 's average Tangible Leverage Ratio.

Within Medical Laboratories industry in the third quarter 2023, 21 other companies have achieved lower Tangible Leverage Ratio than Dermtech Inc in the III Quarter 2023. While Tangible Leverage Ratio total ranking has deteriorated compared to the second quarter 2023 from 1581 to 1615 .

Explain Tangible Leverage Ratio?
What is DMTK Market Share?
What are DMTK´s Total Liabilities?


DMTK Tangible Leverage Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Tangible Equity Change -52.86 % -50.68 % -47.3 % -42.38 % -38.48 %
Y / Y Total Liabilities Change 65.92 % 83.82 % 93.89 % 274.63 % 117.28 %
Tangible Leverage Ratio MRQ 0.89 0.78 0.65 0.53 0.25
DMTK's Total Ranking # 1615 # 1581 # 409 # 727 # 632
Seq. Tangible Equity Change -17.05 % -17.87 % -18.97 % -14.6 % -13.21 %
Seq. Total Liabilities Change -6.04 % -1.26 % 0.23 % 78.43 % 4.1 %



Tangible Leverage Ratio third quarter 2023 Company Ranking
Within: No.
Medical Laboratories Industry # 22
Healthcare Sector # 565
Overall Market # 1615


Tangible Leverage Ratio Statistics
High Average Low
28.71 7.94 0.03
(Dec 31 2018)   (Jun 30 2021)




Financial Statements
Dermtech Inc 's Tangible Equity $ 73 Millions Visit DMTK's Balance sheet
Dermtech Inc 's Total Liabilities $ 65 Millions Visit DMTK's Balance sheet
Source of DMTK's Sales Visit DMTK's Sales by Geography


Cumulative Dermtech Inc 's Tangible Leverage Ratio

DMTK's Tangible Leverage Ratio for the trailling 12 Months

DMTK Tangible Leverage Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Tangible Equity TTM Growth -52.86 % -50.68 % -47.3 % -42.38 % -38.48 %
Y / Y Total Liabilities TTM Growth 65.92 % 83.82 % 93.89 % 274.63 % 117.28 %
Tangible Leverage Ratio TTM 0.68 0.51 0.38 0.27 0.17
Total Ranking TTM # 1560 # 6 # 1 # 249 # 399
Seq. Tangible Equity TTM Growth -17.05 % -17.87 % -18.97 % -14.6 % -13.21 %
Seq. Total Liabilities TTM Growth -6.04 % -1.26 % 0.23 % 78.43 % 4.1 %


On the trailing twelve months basis Despite of the repayements of liabilities of -6.04% in the trailing twelve months ending in III Quarter 2023, Tangible Leverage Ratio improved to 0.68, below Dermtech Inc 's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Laboratories industry 21, during the past 12 months, other companies have achieved lower Tangible Leverage Ratio than Dermtech Inc . While Tangible Leverage Ratio total ranking has deteriorated during the twelve months ending in the III Quarter 2023, compared to the prior period, from 6 to 1560.

Explain Tangible Leverage Ratio?
What is DMTK Market Share?
What are DMTK´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 22
Healthcare Sector # 565
Within the Market # 1560


trailing twelve months Tangible Leverage Ratio Statistics
High Average Low
28.71 7.94 0.03
(Dec 31 2018)   (Jun 30 2021)




Companies with similar Tangible Leverage Ratio in the quarter ending Sep 30 2023, within Medical Laboratories Industry Tangible Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Tangible Equity
Malachite Innovations Inc   1.64 $ 11.227  Millions$ 6.866  Millions
Luna Innovations Inc  1.25 $ 64.304  Millions$ 51.573  Millions
Exagen Inc   1.17 $ 32.286  Millions$ 27.504  Millions
American Shared Hospital Services  1.02 $ 25.247  Millions$ 24.661  Millions
Dermtech Inc   0.89 $ 64.832  Millions$ 73.064  Millions
Natera inc   0.82 $ 646.850  Millions$ 784.658  Millions
Psychemedics Corp  0.76 $ 5.617  Millions$ 7.429  Millions
Omniab Inc   0.69 $ 56.325  Millions$ 81.797  Millions
Bioaffinity Technologies Inc   0.64 $ 3.196  Millions$ 4.997  Millions
Personalis Inc   0.50 $ 75.430  Millions$ 151.206  Millions
Science 37 Holdings Inc   0.40 $ 20.899  Millions$ 51.744  Millions
Enzo Biochem Inc  0.38 $ 28.141  Millions$ 74.275  Millions
Caredx Inc   0.35 $ 107.046  Millions$ 307.471  Millions
Incyte Corporation  0.31 $ 1,456.792  Millions$ 4,646.605  Millions
Butterfly Network inc   0.30 $ 76.803  Millions$ 257.419  Millions
Ispecimen inc   0.28 $ 3.589  Millions$ 12.706  Millions
Veracyte inc   0.27 $ 63.663  Millions$ 237.316  Millions
Absci Corp  0.21 $ 30.348  Millions$ 147.321  Millions
Sera Prognostics Inc   0.19 $ 14.646  Millions$ 75.411  Millions

Date modified: 2023-11-03T13:13:22+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com